Yanxiang Ye Selected Research

Antidepressive Agents (Antidepressants)

4/2024	Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder.
1/2024	The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis.
7/2023	Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.
1/2023	Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder.
1/2022	Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder.
1/2022	Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: A naturalistic follow-up study.
1/2022	The functional connectivity of the middle frontal cortex predicts ketamine's outcome in major depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanxiang Ye Research Topics

Disease

8	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 01/2022
2	Headache (Headaches) 01/2024 - 07/2023
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2023 - 01/2022
1	Treatment-Resistant Depressive Disorder 01/2024
1	Nausea 07/2023
1	Dizziness (Lightheadedness) 07/2023
1	Depressive Disorder (Melancholia) 01/2023
1	Pain (Aches) 01/2023

Drug/Important Bio-Agent (IBA)

7	Antidepressive Agents (Antidepressants)IBA 04/2024 - 01/2022
6	Ketamine FDA LinkGeneric 04/2024 - 01/2022
3	EsketamineIBA 09/2023 - 11/2022
1	PolyaminesIBA 01/2024
1	salicylhydroxamic acid (SHAM)IBA 01/2024